132
Views
19
CrossRef citations to date
0
Altmetric
Review Article

Blood-brain barrier biology and methodology

Pages 556-569 | Received 12 Feb 1999, Accepted 26 Apr 1999, Published online: 10 Jul 2009

References

  • Anthony D, Dempster R, Fearn S, Clements J, Wells G, Perry VH, Walker K. CXC chemokines generate age-related increases in neutrophil mediated brain inflammation and blood-brain barrier breakdown. Current Biology 1998; 8: 923–926
  • Audus KL, Bartel RL, Hidalgo IJ, Borchardt RT-PCR. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res 1990; 7: 435–451
  • Axthelm MK, Krakowka S. Canine distemper virus: the early blood-brain barrier lesion. Acta. Neuropatholog 1987; 75: 27–33
  • Bickel U, Kang YS, Yoshikawa T, Pardridge WM. In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate within brain capillary endothelium. J Histochem Cytochem 1994; 42: 1493–1497
  • Blumcke I, Eggli P, Celio MR. Relationship between astrocyte foot processes and ‘perineuronal nets’ in rat neocortex. GLIA 1995; 15: 131–140
  • Boado RJ, Pardridge WM. Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5′-untranslated region. Mol Cell Neurosci 1990; 1: 224–232
  • Boado RJ, Pardridge WM. A one-step procedure for isolation of poly A+mRNA from isolated brain capillaries and endothelial cells in culture. J Neurochem 1991; 57: 2136–2139
  • Boado RJ, Pardridge WM. Differential expression of α-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells. J Neurosci Res 1994; 39: 430–435
  • Bolton SJ, Anthony DC, Perry VH. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neurosci 1998; 86: 1245–1257
  • Bowman PD, Ennis SR, Rarey KE, Betz AL, Goldstein GW. Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Annal Neurol 1983; 14: 296–402
  • Broman T. Blood-brain barrier damage in multiple sclerosis supravital test-observations. Acta Neurol Scand 1964; 40: 21–24
  • Cancilla PA, Baker RN, Pollack PS, Frommes SP. The reaction of pericytes of the central nervous system to exogenous protein. Lab Invest 1972; 26: 376–383
  • Cohen Z, Ehret M, Maitre M, Hamel E. Ultra-structural analysis of tryptophan hydroxylase immunoreactive nerve terminals in the rat cerebral cortex and hippocampus: their associations with local blood vessels. Neurosci 1995; 66: 555–569
  • Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multi-drug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695–698
  • Daniel PM, Lam DK, Pratt OE. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis. J Neurol Sci 1981; 52: 211–219
  • De Bault LE, Kahn LE, Frommes SP, Cancilla PA. Cerebral microvessels and derived cells in tissue culture: isolation and preliminary characterization. In Vitro 1979; 7: 473–487
  • Dehouck MP, Meresse S, Delorme P, Fruchart JC, Cecchelli R. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 1990; 54: 1798–1801
  • Dore-Duffy P, Washington RA, Balabanov R. Cytokine-mediated activation of cultured CNS micro-vessels: as system for examining antigenic modulation of CNS endothelial cells, and evidence for long-term expression of the adhesion protein E-selectin. J Cereb Blood Flow Metab 1994; 14: 837–844
  • Duffy KR, Pardridge WM. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res 1987; 420: 32–38
  • Durieu-Trautmann O, Federici C, Creminon C, Foignant-Chaverot N, Roux F, Claire M, Strosberg AD, Couraud PO. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J Cell Physiol 1993; 155: 104–111
  • Gendelman HE, Wolinsky JS, Johnson RT, Pressman NJ, Pezeshkpour GH, Boisset GF. Measles encephalomyelitis. Lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination. Ann Neurol 1984; 15: 353–360
  • Golden PL, Pardridge WM. P-glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Res 1999; 819: 143–146
  • Herman IM, D'Amore PA. Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol 1985; 101: 43–52
  • Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94: 2528–2533
  • Hurwitz AA, Berman JW, Rashbaum WK, Lyman WD. Human fetal astrocytes induce the expression of blood-brain barrier specific proteins by autologous endothelial cells. Brain Res 1993; 625: 238–243
  • Jette L, Tetu B, Beliveau R. High levels of P-glycoprotein detected in isolated brain capillaries. Biochim Biophys Acta 1993; 1150: 147–154
  • Kacem K, LaCombe P, Seylaz J, Bonvento G. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: a confocal microscopy study. GLIA 1998; 23: 1–10
  • Kim JW, Closs EI, Albritton LM, Cunningham JM. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 1991; 352: 725–728
  • Kurihara A, Deguchi Y, Pardridge WM. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors. Bioconj Chem 1999; 10: 502–511
  • Lasbennes R, Gayet J. Capacity for energy metabolism in microvessels isolated from rat brain. Neurochem Res 1983; 9: 1–9
  • Liwnicz BH, Leach JL, Yeh HS, Privitera M. Pericyte degeneration and thickening of basement membranes of cerebral microvessels in complex partial seizures: electron microscopic study of surgically removed tissue. Neurosurg 1990; 26: 409–420
  • Mash DC, Pablo J, Flynn DD, Efange SM, Weiner WJ. Characterization and distribution of transferrin receptors in the rat brain. J Neurochem 1990; 55: 1972–1979
  • Mayan WG. Role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier. Brain Res 1996; 743: 70–76
  • Mc Clellan G, Weisberg A, Lin LE, Rose D, Ramaciotti C, Winegrad S. Endothelial cells are required for the cAMP regulation of cardiac contractile proteins. Proc Natl Acad Sci USA 1993; 90: 2885-–2889
  • Meyer J, Rauh J, Galla HJ. The susceptibility of cerebral endothelial cells to astroglial induction of blood-brain barrier enzymes depends on their proliferative state. I Neurochem 1991; 57: 1971–1977
  • Nadal A, Fuentes E, Pastor J, Mc Naughton PA. Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes. Proc Natl Acad Sci USA 1995; 92: 1426-–1430
  • Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 1994; 263: 1768–1772
  • Nehls V, Drenckhahn D. Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 1991; 113: 147–154
  • Pardridge WM. Peptide Drug Delivery to the Brain, WM Pardridge. Raven Press, New York 1991; 1–357
  • Pardridge WM. Blood-brain barrier methodology and biology. Introduction to the Blood-brain Barrier: Methodology, Biology, and Pathology, WM Pardridge. Cambridge University Press, CambridgeUK 1998a; 1–8
  • Pardridge WM. Isolated brain capillaries: an in vitro model of blood-brain barrier research. Introduction to the Blood-Brain Barrier: Methodology, Biology, and Pathology, WM Pardridge. Cambridge University Press, CambridgeUK 1998b; 49–61
  • Pardridge WM. A morphological approach to the analysis of blood-brain barrier transport function. Brain Barrier Systems, O. Paulson, et al. Munksgaard, Copenhagen 1999, Aflred Benzon Symposium 45 In press
  • Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier insulin receptor. J Neurochem 1985; 44: 1541–1550
  • Pardridge WM, Eisenberg J, Yang J, Tourtelotte WW. Isolation of intact capillaries and capillary plasma membranes from frozen human brain. J Neurosci Bes 1987; 18: 352–257
  • Pardridge WM, Golden PL, Kang YS, Bickel U. Brain microvascular and astrocyte localization of p-glycoprotein. J Neurochem 1997; 68: 1278–1285
  • Pardridge WM, Kang YS, Buciak JL, Yang J. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Bes 1995; 12: 807–816
  • Pardridge WM, Triguero D, Yang J, Cancilla PA. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J Pharmacol Exp Ther 1990; 253: 884–891
  • Pardridge WM, Yang J, Buciak J, Tourtellotte WW. Human brain microvascular DR antigen. J Neurosci Res 1989; 23: 337–341
  • Paspalas CD, Papadopoulos GC. Ultrastructural relationships between noradrenergic nerve fibers and non-neuronal elements in the rat cerebral cortex. GLIA 1996; 17: 133–146
  • Paulson OB, Newman EA. Does the release of potassium from astrocyte endfeet regulate cerebral blood flow?. Science 1987; 237: 896–898
  • Pollack IF, Lund RD. The blood-brain barrier protects foreign antigens in the brain from immune attack. Exper Neurol 1990; 108: 114–121
  • Risau W, Dingier A, Albrecht U, Dehouck MP, Cecchelli R. Blood-brain barrier pericytes are the main source of γ-glutamyltranspeptidase activity in brain capillaries. J Neurochem 1992; 58: 667–672
  • Saito Y, Buciak J, Pardridge WM. Vector-mediated delivery of [125I]-labeled β-amyloid peptide Aβ1–40 through the blood-brain barrier and binding to Alzheimer's disease amyloid of the Aβ1–40 vector complex. Proc Natl Acad Sci USA 1995; 90: 10227–10231
  • Smith QR, Rapoport SI. Cerebrovascular permeability coefficients to sodium, potassium and chloride. J Neurochem 1986; 46: 1732–1742
  • Soilu-Hanninen M, Eralinna J-H, Hukkanen V, Roytta M, Salmi AA, Salonen R. Semliki forest vims infects mouse brain endothelial cells and causes blood-brain barrier damage. J Virol 1994; 68: 6291–6298
  • Stanness KA, Westrum LE, Fornaciari E, Mascagni P, Nelson JA, Stenglein SG, Myers T, Janigro D. Morphological and functional characterization of an in vitro blood-brain barrier model. Brain Res 1997; 771: 329–342
  • Stewart PA. Glial-vascular relations. Primer on Cerebrovascular Diseases, K MA Welch, LR Caplan, DL Reis. Academic Press, New York 1994; 17–20
  • Thompson SE, Audus KL. Leucine-enkephalin metabolism in brain microvessel endothelial cells. Peptides 1994; 15: 109–116
  • Tilling T, Korte D, Hoheisel D, Galla HJ. Basement membrane proteins influence brain capillary endothelial barrier function in vitro. J Neurochem 1998; 71: 1151–1157
  • Tsukada N, Behan WM, Behan PO. Search for autoantibodies to endothelial and smooth muscle cells in patients with multiple sclerosis. Acta Neuropath 1985; 66: 134–139
  • Tsukada N, Koh CS, Yanagisawa N, Okano A, Behan WM, Behan PO. A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane. Acta Neuropath 1987; 73: 259–266
  • Van Bree JB, de Boer AG, Verhoef JC, Danhof M, Breimer DD. Transport of vasopressin fragments across the blood-brain barrier: In vitro studies using monolayer cultures of bovine brain endothelial cells. J Pharm Exp Ther 1988; 249: 901–905
  • Vass K, Lassmann H, Wekerle H, Wisniewski HM. The distribution of la antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol 1986; 70: 149–160
  • Washington R, Burton J, Todd RF, Newman W, Dragovic L, Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 1994; 35: 89-–97
  • Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. Inducible expression of H-2 and la antigens on brain cells. Nature 1984; 310: 688–691
  • Wu D, Pardridge WM. CNS pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analogue coupled to a blood-brain barrier drug delivery system. J Pharmacol Exp Ther 1996; 279: 77–83
  • Wu D, Pardridge WM. Neuroprotection with noninvasive neurotrophin delivery to brain. Proc Natl Acad Sci USA 1999; 96: 254–259
  • Wu D, Yang J, Pardridge WM. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J Clin Invest 1997; 100: 2842–2848

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.